Eric D Bateman Selected Research

Eric D Bateman Research Topics

Disease

81	Asthma (Bronchial Asthma) 12/2023 - 01/2003
26	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 07/2002
7	Tuberculosis (Tuberculoses) 01/2017 - 10/2005
4	Symptom Flare Up 01/2022 - 01/2022
4	Obstructive Lung Diseases (Obstructive Lung Disease) 12/2021 - 10/2005
3	Inflammation (Inflammations) 11/2022 - 05/2006
3	Dyspnea (Shortness of Breath) 01/2015 - 07/2002
3	Oral Candidiasis (Thrush) 11/2012 - 08/2007
2	Nasopharyngitis 01/2016 - 05/2015
2	Body Weight (Weight, Body) 05/2015 - 01/2008
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2015 - 10/2005
2	Cough 01/2015 - 09/2012
2	Tremor (Tremors) 10/2013 - 09/2012
1	Hypersensitivity (Allergy) 12/2023
1	Emphysema 01/2020
1	Nasal Polyps (Nasal Polyp) 01/2019
1	Rhinitis 01/2019
1	Rhinosinusitis 01/2019
1	Hematuria 01/2017
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2016
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Airway Obstruction (Choking) 01/2016
1	Hypertension (High Blood Pressure) 09/2015
1	Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome 09/2015
1	Respiratory Sounds (Crackle) 09/2015

Drug/Important Bio-Agent (IBA)

51	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 01/2003
22	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 01/2003
18	Tiotropium Bromide (Spiriva)FDA Link 05/2018 - 07/2002
17	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 01/2004
15	Fluticasone (Cutivate)FDA LinkGeneric 01/2019 - 01/2003
15	fluticasone furoate FDA Link 01/2015 - 10/2011
14	Budesonide (Pulmicort)FDA LinkGeneric 12/2021 - 01/2003
13	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 07/2002
11	vilanterolIBA 01/2019 - 01/2012
10	Muscarinic AntagonistsIBA 01/2022 - 04/2011
10	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 01/2005
6	Formoterol Fumarate Drug Combination Budesonide FDA Link 12/2021 - 01/2003
6	Terbutaline (Brethaire)FDA LinkGeneric 12/2021 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2014
4	Immunoglobulin E (IgE)IBA 12/2023 - 05/2018
4	dupilumabIBA 11/2022 - 01/2022
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2022
4	reslizumabIBA 01/2022 - 05/2015
4	GlucocorticoidsIBA 06/2018 - 09/2012
4	RoflumilastIBA 01/2016 - 08/2005
4	aclidinium bromideIBA 08/2015 - 04/2011
4	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2015 - 12/2013
4	indacaterol-glycopyrronium combinationIBA 01/2015 - 03/2013
4	indacaterolIBA 01/2015 - 09/2012
3	Albuterol (Salbutamol)FDA LinkGeneric 01/2022 - 03/2006
3	montelukast (Singulair)FDA Link 01/2017 - 06/2015
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 08/2011
2	anti-IgE antibodiesIBA 01/2022 - 09/2015
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2021 - 01/2016
2	batefenterolIBA 01/2019 - 10/2013
2	GSK573719IBA 01/2019 - 06/2014
2	Monoclonal AntibodiesIBA 01/2019 - 10/2016
2	Phosphodiesterase 4 InhibitorsIBA 01/2016 - 05/2006
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 02/2014 - 01/2004
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2014 - 08/2005
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 10/2013 - 03/2006
2	ciclesonide FDA Link 08/2013 - 08/2007
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2012 - 01/2012
1	AllergensIBA 12/2023
1	Eosinophil Cationic ProteinIBA 12/2023
1	Tryptases (Tryptase)IBA 12/2023
1	TabletsIBA 12/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2022
1	InterleukinsIBA 01/2022
1	mepolizumabIBA 01/2022
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2022
1	LigandsIBA 01/2022
1	Omalizumab (Xolair)FDA Link 01/2022
1	benralizumabIBA 01/2022
1	Interleukin-13IBA 01/2022
1	Particulate MatterIBA 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	AZD1981IBA 01/2018
1	ProstaglandinsIBA 01/2017
1	VaccinesIBA 01/2017
1	Tuberculosis VaccinesIBA 01/2017
1	fevipiprantIBA 01/2017
1	AERAS-402IBA 01/2017
1	lebrikizumabIBA 10/2016
1	PeriostinIBA 10/2016
1	Antidepressive Agents (Antidepressants)IBA 09/2015
1	BI 671800IBA 06/2015
1	Prostaglandin D2IBA 06/2015
1	prostaglandin D2 receptorIBA 06/2015

Therapy/Procedure

46	Therapeutics 01/2022 - 01/2003
9	Nebulizers and Vaporizers (Inhaler) 01/2023 - 01/2003
5	Biological Therapy 01/2022 - 01/2022
5	Dry Powder Inhalers 01/2019 - 07/2002
2	Bronchial Thermoplasty 09/2015 - 09/2015
2	Metered Dose Inhalers (Metered Dose Inhaler) 01/2004 - 07/2002
1	Immunotherapy 12/2023
1	Aftercare (After-Treatment) 01/2020
1	Self Medication 01/2019
1	Drug Therapy (Chemotherapy) 01/2017